Pharmaceutical Technology on MSN
JPM26: GSK banks on recent AI deals to offset patent expiries
GSK noted recent deals as source of fresh revenues amid patent expiries and an AI-driven boost to drug discovery.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback